Synthekine Announces Key Executive Leadership Changes
Key Highlights Geoff Nosrati, Ph.D., appointed as Chief Business Officer, bringing over 20 years of biotech industry experience. Martin…
Browsing Tag
Nutcracker Therapeutics
1 post